Cyclerion Therapeutics (CYCN) FCF Margin (2019 - 2025)
Cyclerion Therapeutics (CYCN) posted quarterly FCF Margin of 30.17% for Q3 2025, up 85436.0% year-over-year from N/an in Q3 2024, and up 94.42% quarter-over-quarter from 540.86% in Q2 2025.
Cyclerion Therapeutics (CYCN) FCF Margin (2019 - 2025) Analysis & Trends
Cyclerion Therapeutics' FCF Margin history runs 6 years deep, the most recent figure standing at 30.17% for Q3 2025.
- In Q3 2025, FCF Margin rose 85436.0% year-over-year to 30.17%; the TTM figure through Sep 2025 stood at 48.16% (up 316524.0% YoY), while the FY2024 annual figure was 216.65%, changed N/A from the prior year.
- FCF Margin for Q3 2025 stood at 30.17%, up from 540.86% in the prior quarter.
- The five-year high for FCF Margin was 19.93% in Q4 2024, with the low at 23167.74% in Q1 2021.
- The 4-year median for FCF Margin is 1195.06% (2025), against an average of 3196.1%.
- The sharpest annual moves came in 2021 and 2022: FCF Margin slumped 2028618 bps in 2021, then soared 2137534 bps in 2022.
- Cyclerion Therapeutics' FCF Margin stood at 1549.16% in 2021, then sank by 126 bps to 3505.23% in 2022, then surged by 101 bps to 19.93% in 2024, then plunged by 251 bps to 30.17% in 2025.
- Business Quant data shows CYCN's FCF Margin at 30.17% in Q3 2025, 540.86% in Q2 2025, and 1195.06% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 70.82% |
| 10 | Cyclerion Therapeutics | 12.51 Mn | 9.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -30.17% |
| Jun 30, 2025 | -540.86% |
| Mar 31, 2025 | -1,195.06% |
| Dec 31, 2024 | 19.93% |
| Sep 30, 2024 | -884.54% |
| Jun 30, 2022 | -3,505.23% |
| Mar 31, 2022 | -1,792.41% |
| Dec 31, 2021 | -1,549.16% |
| Sep 30, 2021 | -2,331.32% |
| Jun 30, 2021 | -180.57% |
| Mar 31, 2021 | -23,167.74% |
| Dec 31, 2020 | -10,966.92% |
| Sep 30, 2020 | -3,794.00% |
| Jun 30, 2020 | -2,007.08% |
| Mar 31, 2020 | -2,881.56% |
| Dec 31, 2019 | -1,532.95% |
| Sep 30, 2019 | -1,703.29% |
| Jun 30, 2019 | -1,348.28% |